29 results on '"Kampolis, Christos F."'
Search Results
2. Evaluation of Antibody Kinetics Following COVID-19 Vaccination in Greek SARS-CoV-2 Infected and Naïve Healthcare Workers.
- Author
-
Pavlidis, George, Giannoulis, Vasileios, Pirounaki, Maria, Lampropoulos, Ioannis C., Siafi, Eirini, Nitsa, Alkippi, Pavlou, Efthymia, Xanthaki, Anna, Perlepe, Garyfallia, Fortis, Sotirios P., Charalambous, George, Kampolis, Christos F., and Pantazopoulos, Ioannis
- Subjects
MEDICAL personnel ,IMMUNOGLOBULINS ,COVID-19 vaccines ,SARS-CoV-2 - Abstract
We investigated the antibody kinetics after vaccination against COVID-19 in healthcare workers of a Greek tertiary hospital. Eight hundred and three subjects were included, of whom 758 (94.4%) received the BNT162b2 vaccine (Pfizer-BioNTech), eight (1%) mRNA-1273 (Moderna), 14 (1.7%) ChAdOx1 (Oxford-AstraZeneca) and 23 (2.9%) Ad26.COV2.S (Janssen). Before the second dose, at 2, 6 and 9 months after the second dose and at 2 and 6 months after the third dose, anti-spike IgG were quantified by the chemiluminescence microparticle immunoassay method. One hundred subjects were infected before vaccination (group A), 335 were infected after receiving at least one vaccine dose (group B), while 368 had never been infected (group C). Group A presented a greater number of hospitalizations and reinfections compared to group B (p < 0.05). By multivariate analysis, younger age was associated with an increased risk of reinfection (odds ratio: 0.956, p = 0.004). All subjects showed the highest antibody titers at 2 months after the second and third dose. Group A showed higher antibody titers pre-second dose, which remained elevated 6 months post-second dose compared to groups B and C (p < 0.05). Pre-vaccine infection leads to rapid development of high antibody titer and a slower decline. Vaccination is associated with fewer hospitalizations and fewer reinfections. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Establishing a Multidisciplinary Team-Based Pleural Service in the Era of Financial Austerity: The Role of the Thoracic Surgeon.
- Author
-
Kapetanakis, Emmanouil I., Sidiropoulou, Tatiana, Tomos, Ioannis P., Kampolis, Christos F., Raptakis, Thomas, and Tomos, Periklis I.
- Subjects
VIDEO-assisted thoracic surgery ,PULMONOLOGISTS ,AUSTERITY ,FINANCIAL services industry ,SURGEONS ,THORACOSCOPY - Abstract
Medical thoracoscopy/pleuroscopy has become, after bronchoscopy, the second most commonly utilized endoscopic procedure in interventional pulmonology. Due to their common origin, medical thoracoscopy/pleuroscopy and video-assisted thoracic surgery (VATS) are quite similar procedures technically. In contrast to the prevailing attitude that it should predominantly be performed by interventional pulmonologists, we believe that, like all hybrid-in-nature techniques, it should be implemented as part of a combined specialist care service/team. Herewith, we describe our attempt to establish a multidisciplinary pleural disease program during a difficult economic period for our country, comprising thoracic surgeons, pulmonologists and anesthesiologists, all of whom brought in their experience, expertise and resources to establish and develop the service resulting in a hybridization of the technique, with, as reported, quite favorable results. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Comparison of advanced closed-loop ventilation modes with pressure support ventilation for weaning from mechanical ventilation in adults: A systematic review and meta-analysis
- Author
-
Kampolis, Christos F. Mermiri, Maria Mavrovounis, Georgios and Koutsoukou, Antonia Loukeri, Angeliki A. Pantazopoulos, Ioannis
- Abstract
Purpose: To compare neurally adjusted ventilatory assist (NAVA), proportional assist ventilation (PAV), adaptive support ventilation (ASV) and Smartcare pressure support (Smartcare/PS) with standard pressure support ventilation (PSV) regarding their effectiveness for weaning critically ill adults from invasive mechanical ventilation (IMV). Methods: Electronic databases were searched to identify parallel-group randomized controlled trials (RCTs) comparing NAVA, PAV, ASV, or Smartcare/PS with PSV, in adult patients under IMV through July 28, 2021. Primary outcome was weaning success. Secondary outcomes included weaning time, total MV duration, reintubation or use of non-invasive MV (NIMV) within 48 h after extubation, in-hospital and intensive care unit (ICU) mortality, in-hospital and ICU length of stay (LOS) (PROSPERO registration No:CRD42021270299). Results: Twenty RCTs were finally included. Compared to PSV, NAVA was associated with significantly lower risk for in-hospital and ICU death and lower requirements for post-extubation NIMV. Moreover, PAV showed significant advantage over PSV in terms of weaning rates, MV duration and ICU LOS. No significant differences were found between ASV or Smart care/PS and PSV. Conclusions: Moderate certainty evidence suggest that PAV increases weaning success rates, shortens MV duration and ICU LOS compared to PSV. It is also noteworthy that NAVA seems to improve in-hospital and ICU survival. (c) 2021 Elsevier Inc. All rights reserved.
- Published
- 2022
5. Cryptogenic organizing pneumonia in Sweetʼs syndrome: case report and review of the literature
- Author
-
Tzelepis, Elias, Kampolis, Christos F., Vlachadami, Ioanna, Moschovi, Maria, Alamani, Maria, and Kaltsas, Gregory
- Published
- 2016
- Full Text
- View/download PDF
6. Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?.
- Author
-
PAVLIDIS, GEORGE, KAMPOLIS, CHRISTOS F., PERLEPE, GARYFALLIA, PAGONIS, ATHANASIOS, MANIOTIS, CHRISTOS, KOULLIAS, EMMANOUIL, KRANIDIOTI, HARIKLIA, KYRITSIS, ATHANASIOS, PAVLOU, EFTHIMIA, SINIS, SOTIRIOS, PIROUNAKI, MARIA, VASSILOPOULOS, DIMITRIOS, GOURGOULIANIS, KONSTANTINOS, and PANTAZOPOULOS, IOANNIS
- Subjects
COVID-19 pandemic ,HEALTH outcome assessment ,IMMUNOGLOBULINS ,HOSPITAL patients ,POLYMERASE chain reaction - Abstract
Background/Aim: The relationship between the kinetics of antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the severity of Coronavirus Disease 2019 (COVID-19) is poorly understood. The aim of the present study was to investigate whether serum SARS-CoV-2 antibody kinetics serve as an early predictor of clinical deterioration or recovery in hospitalized patients with COVID-19. Patients and Methods: In this prospective observational study, 102 consecutive patients (median age: 60 years, 58% males) with symptomatic COVID-19 infection diagnosed by real-time polymerase chain reaction assay, hospitalized in two tertiary hospitals, were included. Rapid test for qualitative detection of immunoglobulin M (IgM) and immunoglobulin G (IgG) SARS-CoV-2 antibodies was performed at pre-defined time intervals during hospitalization (days: 0, 3, 7, 10, 14, 21 and 28). Results: During a 3-month follow-up period after COVID-19 disease onset, a total of 87 patients were discharged, 12 patients were intubated and entered the Intensive Care Unit, and three patients died. The median time for seroconversion was 10 days for IgM and 12 days for IgG post onset of symptoms. Univariate logistic regression analysis found no associations between IgM or IgG positivity and clinical outcomes or complications during hospitalization for COVID-19 infection. Diabetes and dyslipidemia were the only clinical risk factors predictive of COVID-19-related complications during hospitalization. Conclusion: SARS-CoV-2 antibody responses do not predict clinical outcome in hospitalized patients with moderate-tosevere COVID-19 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. The Role of Bronchoscopic Findings and Bronchoalveolar Lavage Fluid Cytology in Early Diagnosis of Ventilator-Associated Pneumonia
- Author
-
Vernikos, Pavlos Kampolis, Christos F. Konstantopoulos, Konstantinos Armaganidis, Apostolos Karakitsos, Petros
- Subjects
respiratory tract diseases - Abstract
BACKGROUND: Early diagnosis of ventilator-associated pneumonia (VAP) is necessary to reduce morbidity and improve survival of critically ill patients in the ICU. The purpose of the present study is to examine the performance of macroscopic bronchoscopic findings and cytological analysis of bronchoalveolar lavage fluid (BALF) as an early diagnostic tool for VAP, either alone or in combination with clinically oriented scores (modified Clinical Pulmonary Infection Score [CPIS] or Johanson criteria). METHODS: BAL was performed in 54 consecutive mechanically ventilated subjects. The predictive value of isolated or combined clinical characteristics, BALF, and/or other laboratory measurements in diagnosing VAP was analyzed by logistic regression analysis. A separate diagnostic score was derived from a linear combination of independent variables included in the multivariate model and compared with CPIS, Johanson criteria, and their combinations with BALF cytology (receiver operating characteristic curve analysis). RESULTS: Integrating relative neutrophil cell count in CPIS or Johanson criteria optimized their specificity (>80%) but decreased sensitivity (
- Published
- 2016
8. Cryptogenic organizing pneumonia in Sweet's syndrome: case report and review of the literature
- Author
-
Tzelepis, Elias Kampolis, Christos F. Vlachadami, Ioanna and Moschovi, Maria Alamani, Maria Kaltsas, Gregory
- Abstract
Background and AimsSweet's syndrome or acute febrile neutrophilic dermatosis is characterized by fever, leukocytosis and tender erythematous plaques, which show infiltration by mature neutrophils on histological examination. Pulmonary involvement is rare in Sweet's syndrome. MethodWe describe the case of a 17-year-old man with a myelodysplastic syndrome following therapy for Hodgkin's lymphoma who developed Sweet's syndrome and cryptogenic organizing pneumonia. In addition, we conducted a review of the related English literature. ResultsLiterature review yielded six similar reports of biopsy-proven cryptogenic organizing pneumonia associated with Sweet's syndrome. We present the clinical and laboratory characteristics, as well as the response to treatment, of all cases of cryptogenic organizing pneumonia reported in patients with Sweet's syndrome. ConclusionsCryptogenic organizing pneumonia is a rare manifestation of Sweet's syndrome, which may be complicated by respiratory failure. Prompt treatment with corticosteroids usually leads to clinical and radiographic improvement.
- Published
- 2016
9. How can autoantibodies predict the long-term outcome of patients with interstitial lung disease? Results from a retrospective cohort study.
- Author
-
Kampolis, Christos F., Venetsanopoulou, Aliki I., Karakontaki, Foteini, Polychronopoulos, Vlasis, Vlachoyiannopoulos, Panayiotis, and Tzioufas, Athanasios G.
- Subjects
- *
AUTOANTIBODIES , *INTERSTITIAL lung diseases , *HIGH resolution imaging , *COMPUTED tomography , *PULMONARY function tests , *RETROSPECTIVE studies - Abstract
Abstract Objectives This study aimed to investigate whether positive serum autoantibodies (AAbs) have any impact on survival and time evolution of radiological findings and pulmonary function indices in patients with interstitial lung disease (ILD). Patients and methods Ninety four patients with regular clinical, functional and high resolution computed tomography (HRCT) imaging follow-up for at least 12 consecutive months and complete testing for a panel of AAbs most commonly associated with ILD were enrolled in this retrospective two-center study. Eligible patients were divided into two groups based on the presence [ILD/AAb(+)] (n = 69) or absence [ILD/AAb(−)] (n = 25) of positive serum AAbs. All-cause mortality and longitudinal indicators of ILD progression such as a sustained decrease from baseline in absolute measurements of forced vital capacity (FVC) of ≥10% or single-breath diffusion capacity (DLCO SB) of ≥15% were the primary study endpoints. DLCO SB < 40% predicted on at least two consecutive measurements and progression of HRCT findings were our secondary endpoints. Kaplan–Meier (K-M) survival analysis and multivariate Cox proportional-hazards (PH) model were used to evaluate the prognostic significance of positive AAbs in the outcome of patients with ILD. Results ILD/AAb(+) patients were predominantly female (71% vs 32%), were significantly younger (54.8 ± 14.6 vs 66.8 ± 10.1 years), and had longer duration of follow-up (78.1 ± 53.1 vs 41.6 ± 26.7 months), compared with ILD/AAb(−) patients (p <.01 for each comparison). Baseline measurements of FVC (% pred.) and DLCO SB (% pred.) did not differ significantly between the two groups. At the end of follow-up, mortality rates and the percentage of patients with a sustained FVC decrease were lower in the ILD/AAb(+) group (p <.05 for each comparison). With the exception of DLCO SB < 40% pred., ILD/AAb(+) patients had a longer median time-to-event for each of the other studied outcomes (p <.01 for each K-M analysis). In addition, Cox PH models adjusted for age, smoking status, baseline pulmonary function tests and morphological pattern of ILD remained statistically significant in favor of the ILD/AAb(+) group (p <.05 for each comparison). Conclusions AAb(+) patients with ILD seem to have a more favorable prognosis regarding all-cause mortality, long-term deterioration in lung function parameters and progression of HRCT findings than their AAb (−) counterparts. Highlights • Long-term, clinically meaningful decrease of FVC or DLCO SB was observed in >50% of patients with ILD. • AAb positivity in patients with ILD is associated with lower mortality rates and prolonged survival. • PFTs and HRCT findings deteriorate less rapidly in ILD/AAb(+) than ILD/AAb(−) patients. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Benign Metastasizing Leiomyoma Presenting as Cavitating Lung Nodules
- Author
-
Loukeri, Angeliki A. Pantazopoulos, Ioannis N. Tringidou, Rodoula Giampoudakis, Pantelis Valaskatzi, Argyro Loukeri, Pinelopi A. Kampolis, Christos F.
- Abstract
Benign metastasizing leiomyoma (BML) was initially used to describe single or multiple pulmonary nodules composed of proliferating smooth muscle cells (lacking cellular atypia) in premenopausal females 3 months to 20 y after hysterectomy for uterine leiomyoma. The lung is the most commonly involved site, thus including many malignant and benign entities in the differential diagnosis. The present case refers to a 47-y-old premenopausal woman with a history of subtotal hysterectomy for a uterine leiomyoma presenting with bilateral cavitating pulmonary nodules. A number of nodules were resected by video-assisted thoracoscopic surgery. The histological findings in correlation with the immunohistochemical results were consistent with the diagnosis of BML. A bilateral salpingooophorectomy was performed, combined with complete removal of the remaining cervix. One year later, the subject remains asymptomatic, and the pulmonary nodules are stable with regard to number, size, location, and morphology.
- Published
- 2014
11. A case study of polypharmacy management in nine European countries: Implications for change management and implementation.
- Author
-
McIntosh, Jennifer, Alonso, Albert, MacLure, Katie, Stewart, Derek, Kempen, Thomas, Mair, Alpana, Castel-Branco, Margarida, Codina, Carles, Fernandez-Llimos, Fernando, Fleming, Glenda, Gennimata, Dimitra, Gillespie, Ulrika, Harrison, Cathy, Illario, Maddalena, Junius-Walker, Ulrike, Kampolis, Christos F., Kardas, Przemyslaw, Lewek, Pawel, Malva, João, and Menditto, Enrica
- Subjects
POLYPHARMACY ,CHANGE management ,DRUG marketing ,TELECOMMUNICATION systems ,HOSPITAL care - Abstract
Background: Multimorbidity and its associated polypharmacy contribute to an increase in adverse drug events, hospitalizations, and healthcare spending. This study aimed to address: what exists regarding polypharmacy management in the European Union (EU); why programs were, or were not, developed; and, how identified initiatives were developed, implemented, and sustained. Methods: Change management principles (Kotter) and normalization process theory (NPT) informed data collection and analysis. Nine case studies were conducted in eight EU countries: Germany (Lower Saxony), Greece, Italy (Campania), Poland, Portugal, Spain (Catalonia), Sweden (Uppsala), and the United Kingdom (Northern Ireland and Scotland). The workflow included a review of country/region specific polypharmacy policies, key informant interviews with stakeholders involved in policy development and implementation and, focus groups of clinicians and managers. Data were analyzed using thematic analysis of individual cases and framework analysis across cases. Results: Polypharmacy initiatives were identified in five regions (Catalonia, Lower Saxony, Northern Ireland, Scotland, and Uppsala) and included all care settings. There was agreement, even in cases without initiatives, that polypharmacy is a significant issue to address. Common themes regarding the development and implementation of polypharmacy management initiatives were: locally adapted solutions, organizational culture supporting innovation and teamwork, adequate workforce training, multidisciplinary teams, changes in workflow, redefinition of roles and responsibilities of professionals, policies and legislation supporting the initiative, and data management and information and communication systems to assist development and implementation. Depending on the setting, these were considered either facilitators or barriers to implementation. Conclusion: Within the studied EU countries, polypharmacy management was not widely addressed. These results highlight the importance of change management and theory-based implementation strategies, and provide examples of polypharmacy management initiatives that can assist managers and policymakers in developing new programs or scaling up existing ones, particularly in places currently lacking such initiatives. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
12. European Innovation Partnership on Active and Healthy Ageing: The Case of the Greek EIP on AHA Network.
- Author
-
Grintzali, Georgia, Vontetsianos, Angelos, Gennimata, Dimitra, Kampolis, Christos F, Papakyriakou, Dimitrios, and Boskou, George
- Published
- 2017
- Full Text
- View/download PDF
13. The Role of Bronchoscopic Findings and Bronchoalveolar Lavage Fluid Cytology in Early Diagnosis of Ventilator-Associated Pneumonia.
- Author
-
Vernikos, Pavlos, Kampolis, Christos F., Konstantopoulos, Konstantinos, Armaganidis, Apostolos, and Karakitsos, Petros
- Subjects
PNEUMONIA diagnosis ,BRONCHOALVEOLAR lavage ,BRONCHOSCOPY ,CONFIDENCE intervals ,CRITICALLY ill ,CYTOLOGY ,PATIENTS ,STATISTICS ,MECHANICAL ventilators ,PREDICTIVE tests ,RECEIVER operating characteristic curves ,EARLY diagnosis ,DATA analysis software ,DESCRIPTIVE statistics ,ODDS ratio ,MANN Whitney U Test ,KRUSKAL-Wallis Test - Abstract
BACKGROUND: Early diagnosis of ventilator-associated pneumonia (VAP) is necessary to reduce morbidity and improve survival of critically ill patients in the ICU. The purpose of the present study is to examine the performance of macroscopic bronchoscopic findings and cytological analysis of bronchoalveolar lavage fluid (BALF) as an early diagnostic tool for VAP, either alone or in combination with clinically oriented scores (modified Clinical Pulmonary Infection Score [CPIS] or Johanson criteria). METHODS: BAL was performed in 54 consecutive mechanically ventilated subjects. The predictive value of isolated or combined clinical characteristics, BALF, and/or other laboratory measurements in diagnosing VAP was analyzed by logistic regression analysis. A separate diagnostic score was derived from a linear combination of independent variables included in the multivariate model and compared with CPIS, Johanson criteria, and their combinations with BALF cytology (receiver operating characteristic curve analysis). RESULTS: Integrating relative neutrophil cell count in CPIS or Johanson criteria optimized their specificity (>80%) but decreased sensitivity (<70%). Radiographic progression and the presence of distal purulent secretions on bronchoscopy were independently associated with VAP diagnosis. A new score that incorporates clinical, radiographic, and early bronchoscopic findings presented excellent diagnostic accuracy (area under curve = 0.96, sensitivity 94.3%, specificity 84.2%). CONCLUSIONS: The diagnostic performance of classical clinical scores for VAP did not improve after combination with BALF cytology. A new composite score proved to be more accurate than previous scores in early VAP diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
14. Diagnosis, treatment and prognosis of lung abscess.
- Author
-
Loukeri, Angeliki A., Kampolis, Christos F., Tomos, Periklis, Papapetrou, Dimosthenis, Pantazopoulos, Ioannis, Tzagkaraki, Aikaterini, Veldekis, Dimitrios, and Lolis, Nikolaos
- Subjects
- *
LUNG diseases , *ABSCESSES , *BACTERIAL diseases , *SEPSIS , *ANAEROBIC bacteria - Abstract
Lung abscesses are usually caused by anaerobic or mixed bacterial infection of the lower respiratory tract. Conservative treatment with broad-spectrum antibiotics is established as the therapy of choice for most patients, with 80-95% responding to antimicrobial therapy. Conservative management failure, manifested by sepsis persistence and/or abscess complications, requires drainage with invasive techniques (percutaneous, endoscopic or surgical) or open surgical removal of the affected lung tissue (segmentectomy, lobectomy or rarely pneumonectomy) in patients with good performance status and sufficient respiratory reserve. Although surgical intervention is accompanied by relatively high mortality rates (11%-28%), it remains the most effective method in preventing complications or future relapses. [ABSTRACT FROM AUTHOR]
- Published
- 2015
15. Surgical correction of acquired unilateral diaphragmatic paralysis by plication technique.
- Author
-
Kampolis, Christos F., Loukeri, Angeliki A., Pikazis, Dimitrios, Stavroulias, Antonios, Spartalis, Eleftherios, and Tomos, Periklis
- Subjects
- *
DIAPHRAGM diseases , *SPIROMETRY - Abstract
Acquired diaphragmatic paralysis may compromise lung mechanics and cause dyspnoea and/or lead to respiratory failure in the long term. A 76 year-old female patient presented with progressive worsening of dyspnoea and spirometric indices, and imaging studies revealed elevation of the left hemidiaphragm. Surgical correction was carried out by diaphragmatic plication technique, through a mini-thoracotomy approach. Immediate alleviation (within days) of her symptoms was observed, while improvement of radiological and pulmonary function tests occurred some weeks later. [ABSTRACT FROM AUTHOR]
- Published
- 2013
16. Inhaled beta2-agonists and beta-blockers in patients with chronic obstructive pulmonary disease and cardiovascular comorbidities: therapeutic dilemmas, myths and realities.
- Author
-
Loukeri, Angeliki A., Kampolis, Christos F., Tatsis, Iraklis, Loukeri, Penelope S. N., Tzagaraki, Aikaterini, and Kythreotis, Prokopis
- Subjects
- *
ADRENERGIC beta blockers , *OBSTRUCTIVE lung diseases , *COMORBIDITY , *CARDIOVASCULAR diseases , *ARRHYTHMIA , *CORONARY disease , *HEART failure - Abstract
Chronic obstructive pulmonary disease (COPD) has been shown to be associated with increased risk for cardiovascular events. The wide distribution of beta-adrenergic receptors in the respiratory and cardiovascular systems frequently discourages clinicians from using beta-blockers in patients with COPD or inhaled beta2-agonists in those with cardiovascular comorbidities. Evidence in the current literature suggests that inhaled short- and long-acting beta2-agonists can be considered safe in patients without significant cardiac disease or with clinically stable disease (arrhythmia, coronary artery disease or heart failure). In these situations COPD treatment should be initiated or adjusted rationally, provided that worsening of respiratory symptoms is not associated with decompensated heart failure or an acute coronary event. Cardioselective beta-blockers in usual doses should not be withheld from patients with COPD who have mild to severe airway obstruction, in whom their definite therapeutic benefits in the management of myocardial infarction and chronic heart failure outweigh the danger of possible induction of bronchospasm. Further research is necessary on the safety of beta-blockers in very severe stages of COPD (FEV1 <30% pred.) and the use of non-cardioselective beta-blockers in subjects with partially reversible airway obstruction. [ABSTRACT FROM AUTHOR]
- Published
- 2013
17. Limited resection procedure for metachronous lung neoplasm.
- Author
-
Kampolis, Christos F., Loukeri, Angeliki A., Lahanas, Elias, Lolis, Nikolaos V., Spartalis, Eleftherios, and Tomos, Periklis
- Subjects
- *
SURGICAL excision , *LUNG tumors , *TUMORS , *NEUROENDOCRINE tumors , *CARCINOID - Abstract
A 57 year-old male smoker presented with weight loss and hypertrophic osteoarthropathy. Imaging studies revealed a solid mass (maximum diameter 4.2 cm) located in the left lung and left upper lobectomy was carried out. Histopathology showed low differentiated adenocarcinoma and the patient received adjuvant chemotherapy. Bronchoscopy performed 3 years later to exclude specific infection revealed complete obstruction of the posterior segment of the right upper lobe by a highly vascular, smooth margined mass. At thoracotomy the frozen section was negative for malignancy and histopathological examination revealed a typical carcinoid tumour. The excellent prognosis of this histological type of tumour allowed avoidance of a major surgical procedure and the lesion was resected by bronchotomy with reconstruction of the bronchial gap. Pneumon 2012, 25(4):428-431. [ABSTRACT FROM AUTHOR]
- Published
- 2012
18. Medication review and polypharmacy management in the hospital setting. The cases of Greece and Catalonia.
- Author
-
Gennimata, Dimitra, Kampolis, Christos F., Vontetsianos, Theodore, Mcintosh, Jennifer, Codina, Carles, Alonso, Albert, and Mair, Alpana
- Subjects
- *
POLYPHARMACY , *HOSPITAL administration , *OLDER people - Abstract
Introduction: Medication review and polypharmacy management, especially in the elderly, are key components of integrated care. Although polypharmacy management is often associated with the primary care setting, hospital clinicians, who are often members of multidisciplinary therapeutic teams, have an opportunity to improve the management of polypharmacy, which has the potential to improve health outcomes in both hospital and primary care. Methods: Mixed-methods (desk reviews, key informant interviews and focus groups) case studies were carried out in Greece and Catalonia, in the framework of the SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) project, in order to describe policies and procedures on the management of polypharmacy and adherence in the elderly and describe implementation strategies. Kotter's Eight Step Process for transforming change and normalization process theory (NPT) were applied both in data collection tools and in the analysis. Progress report: At both sites there was awareness regarding the need for management of polypharmacy in the elderly, although in Greece awareness had not translated to a sense of urgency, a critical early step in Kotter's process. Barriers to implementation in Greece included extreme financial pressure, lack or organizational culture supporting multidisciplinary teams and shared decision making, and lack of guidance from central health authorities. However, despite the lack of national guidelines, hospital pharmacists in state (public) hospitals currently review medication for inpatients and out-patients, and interventions regarding inappropriate polypharmacy and reconciliation of care have been piloted. In Catalonia, implementation of an Institutional network sponsored model has been implemented and it is being evaluated. Polypharmacy was integrated as a specific component of a broader patientcentered service model, driven by a small multidisciplinary team, with a focus on global health outcomes. Facilitators, to implementation included an organizational culture of innovation and shared decision making, advanced training requirements of all hospital pharmacists, and regional health policies focusing on improved care for patients with complex chronic disease. Conclusion and future work: Although Greece is a country with no programme of polypharmacy management identified, there are some policies and clinical activities in place that could support future programmes. National guidance will ultimately be needed to mobilize health professionals and ensure consistency of care. The Catalan experience demonstrates that polypharmacy management can occur in the hospital setting. Future challenges include scaling the current model into other units within the hospital and into primary care. Given the pharmacist training and current medicines management activities in Greece, the hospital may be an appropriate entry point for polypharmacy management activities in that country, later scaling up to the community. As other health systems look to address polypharmacy, hospital should be considered a potential starting point for initiating a programme. Funding: This poster is part of the SIMPATHY project (663082) which has received funding from the European Union's Health Programme (2014-2020). [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
19. Polypharmacy and Adherence: Key Components of Integrated Care The case of Greece.
- Author
-
Gennimata, Dimitra, Kampolis, Christos F., Vontetsianos, Theodore, Geitona, Mary, McIntosh, Jennifer, and consortium, SIMPATHY
- Subjects
- *
POLYPHARMACY , *PATIENT compliance , *INTEGRATED health care delivery , *HEALTH programs , *PUBLIC health - Abstract
Introduction: Polypharmacy and medication adherence in the older population are significant public health issues throughout the European Union (EU), and are critical issues in integrated care. SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) is a consortium of 10 organizations representing 8 EU countries with the goal of stimulating innovation around polypharmacy and adherence, ultimately providing the tools for EU policy makers to adopt new programs addressing this issue into existing healthcare systems. Methods: A mixed-methods case study is ongoing in Greece to identify policies on the management of polypharmacy and adherence issues in the elderly. A desk review of the polypharmacy and adherence policies at the government, regional and institutional level has been completed. Legislation, regulations, guidance and other policy documents from the National Organization for Healthcare Services Provision, the Direction of Pharmaceutical Policy of the Greek Ministry of Health, the 1st Regional Healthcare Authority (RHA) of Attica (about 5 million inhabitants), the public body which is responsible for electronic prescription at a national level and the National Organization of Medicines were analyzed. Key informant interviews will be conducted with policymakers and health professionals responsible for developing and implementing strategies. Focus groups consisting of policymakers, clinicians and patients will then be used to validate the research findings. Progress report: The desk review highlighted several surveys illustrating the extent of inappropriate polypharmacy in various settings and geographic areas of Greece, but did not recognize any type of national, regional or local policies, guidelines and legislation regarding polypharmacy and adherence. Currently, most prescribers use disease-specific guidelines (therapeutic protocols), and local initiatives lead by community pharmacists and/or other healthcare professionals address some aspects of, but do not constitute structured, comprehensive programs on polypharmacy management. Health spending in Greece has dropped in each of the years since 2009, driven by a sharp reduction in public spending as part of government-wide efforts to reduce the large budgetary deficit. Implementation of e-prescription at a national level contributed to the rationalization and modernization of medicine prescription and decreased pharmaceutical costs in the country, but did not directly address the issue of polypharmacy and medication adherence. Conclusion and future work: Results from key informant interviews and focus groups are expected to elucidate the possible constraints and barriers to conceptualization and implementation of polypharmacy programs in Greece. The results from this study combined with the other SIMPATHY case studies will provide valuable tools for policymakers, researchers, and clinicians throughout Europe as they move to integrate polypharmacy and adherence activities into existing health care systems. Funding: This poster is part of the SIMPATHY project (663082) which has received funding from the European Union's Health Programme (2014-2020). [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
20. Pseudochylothorax in a Patient with Rheumatoid Arthritis.
- Author
-
KAMPOLIS, CHRISTOS F. and VLACHOYIANNOPOULOS, PANAYIOTIS G.
- Published
- 2019
- Full Text
- View/download PDF
21. A case study of polypharmacy management in nine European countries : implications for change management and implementation
- Author
-
Jennifer McIntosh, Albert Alonso, Katie MacLure, Derek Stewart, Thomas Kempen, Alpana Mair, Margarida Castel-Branco, Carles Codina, Fernando Fernandez-Llimos, Glenda Fleming, Dimitra Gennimata, Ulrika Gillespie, Cathy Harrison, Maddalena Illario, Ulrike Junius-Walker, Christos F Kampolis, Przemyslaw Kardas, Pawel Lewek, João Malva, Enrica Menditto, Claire Scullin, Birgitt Wiese, SIMPATHY Consortium, Mcintosh, Jennifer, Alonso, Albert, Maclure, Katie, Stewart, Derek, Kempen, Thoma, Mair, Alpana, Castel-Branco, Margarida, Codina, Carle, Fernandez-Llimos, Fernando, Fleming, Glenda, Gennimata, Dimitra, Gillespie, Ulrika, Harrison, Cathy, Illario, Maddalena, Junius-Walker, Ulrike, Kampolis, Christos F., Kardas, Przemyslaw, Lewek, Pawel, Malva, João, Menditto, Enrica, Scullin, Claire, and Wiese, Birgitt
- Subjects
medicine.medical_specialty ,Critical Care and Emergency Medicine ,Medical Doctors ,General Science & Technology ,Health Care Providers ,Geriatrik ,lcsh:Medicine ,european consortium ,Primary care ,Pharmacists ,03 medical and health sciences ,0302 clinical medicine ,Nursing ,Physicians ,Political science ,Medicine and Health Sciences ,medicine ,Humans ,European commission ,adherence ,Medical Personnel ,030212 general & internal medicine ,Disease management (health) ,lcsh:Science ,Primary Care ,Allied Health Care Professionals ,Geriatrics ,Polypharmacy ,Health Care Policy ,Multidisciplinary ,030503 health policy & services ,lcsh:R ,Health Services Administration and Management ,Change management ,Disease Management ,Europe ,Health Care ,Professions ,Health program ,People and Places ,lcsh:Q ,Population Groupings ,0305 other medical science ,Research Article - Abstract
© 2018 McIntosh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Background Multimorbidity and its associated polypharmacy contribute to an increase in adverse drug events, hospitalizations, and healthcare spending. This study aimed to address: what exists regarding polypharmacy management in the European Union (EU); why programs were, or were not, developed; and, how identified initiatives were developed, implemented, and sustained. Methods Change management principles (Kotter) and normalization process theory (NPT) informed data collection and analysis. Nine case studies were conducted in eight EU countries: Germany (Lower Saxony), Greece, Italy (Campania), Poland, Portugal, Spain (Catalonia), Sweden (Uppsala), and the United Kingdom (Northern Ireland and Scotland). The workflow included a review of country/region specific polypharmacy policies, key informant interviews with stakeholders involved in policy development and implementation and, focus groups of clinicians and managers. Data were analyzed using thematic analysis of individual cases and framework analysis across cases. Results Polypharmacy initiatives were identified in five regions (Catalonia, Lower Saxony, Northern Ireland, Scotland, and Uppsala) and included all care settings. There was agreement, even in cases without initiatives, that polypharmacy is a significant issue to address. Common themes regarding the development and implementation of polypharmacy management initiatives were: locally adapted solutions, organizational culture supporting innovation and teamwork, adequate workforce training, multidisciplinary teams, changes in workflow, redefinition of roles and responsibilities of professionals, policies and legislation supporting the initiative, and data management and information and communication systems to assist development and implementation. Depending on the setting, these were considered either facilitators or barriers to implementation. Conclusion Within the studied EU countries, polypharmacy management was not widely addressed. These results highlight the importance of change management and theory-based implementation strategies, and provide examples of polypharmacy management initiatives that can assist managers and policymakers in developing new programs or scaling up existing ones, particularly in places currently lacking such initiatives.
- Published
- 2018
22. Small Airways Dysfunction and Lung Hyperinflation in Long COVID-19 Patients as Potential Mechanisms of Persistent Dyspnoea.
- Author
-
Vontetsianos A, Chynkiamis N, Anagnostopoulou C, Lekka C, Zaneli S, Anagnostopoulos N, Rovina N, Kampolis CF, Papaioannou AI, Kaltsakas G, Vogiatzis I, Stratakos G, Bakakos P, and Koulouris N
- Subjects
- Humans, Middle Aged, Male, Female, Lung physiopathology, Lung diagnostic imaging, SARS-CoV-2, Adult, Post-Acute COVID-19 Syndrome, Aged, COVID-19 physiopathology, COVID-19 complications, Dyspnea physiopathology, Dyspnea etiology, Respiratory Function Tests
- Abstract
Background: Reticulation, ground glass opacities and post-infection bronchiectasis are present three months following hospitalisation in patients recovering from SARS-CoV-2 infection and are associated with the severity of acute infection. However, scarce data exist on small airways impairment and lung hyperinflation in patients with long COVID-19., Aim: To evaluate small airways function and lung hyperinflation in previously hospitalised patients with long COVID-19 and their association with post-COVID-19 breathlessness., Methods: In total, 33 patients (mean ± SD, 53 ± 11 years) with long COVID-19 were recruited 149 ± 90 days following hospital discharge. Pulmonary function tests were performed and lung hyperinflation was defined as RV/TLC ≥ 40%. Small airways function was evaluated by measuring the closing volume (CV) and closing capacity (CC) using the single-breath nitrogen washout technique (SBN
2 W)., Results: CC was 115 ± 28% pred. and open capacity (OC) was 90 ± 19. CC was abnormal in 13 patients (39%), CV in 2 patients (6.1%) and OC in 9 patients (27%). Lung hyperinflation was present in 15 patients, whilst the mean mMRC score was 2.2 ± 1.0. Lung hyperinflation was associated with CC (r = 0.772, p = 0.001), OC (r = 0.895, p = 0.001) and mMRC (r = 0.444, p = 0.010)., Conclusions: Long COVID-19 patients present with small airways dysfunction and lung hyperinflation, which is associated with persistent dyspnoea, following hospitalisation.- Published
- 2024
- Full Text
- View/download PDF
23. Comparison of advanced closed-loop ventilation modes with pressure support ventilation for weaning from mechanical ventilation in adults: A systematic review and meta-analysis.
- Author
-
Kampolis CF, Mermiri M, Mavrovounis G, Koutsoukou A, Loukeri AA, and Pantazopoulos I
- Subjects
- Adult, Humans, Intensive Care Units, Positive-Pressure Respiration, Ventilator Weaning, Interactive Ventilatory Support, Respiration, Artificial
- Abstract
Purpose: To compare neurally adjusted ventilatory assist (NAVA), proportional assist ventilation (PAV), adaptive support ventilation (ASV) and Smartcare pressure support (Smartcare/PS) with standard pressure support ventilation (PSV) regarding their effectiveness for weaning critically ill adults from invasive mechanical ventilation (IMV)., Methods: Electronic databases were searched to identify parallel-group randomized controlled trials (RCTs) comparing NAVA, PAV, ASV, or Smartcare/PS with PSV, in adult patients under IMV through July 28, 2021. Primary outcome was weaning success. Secondary outcomes included weaning time, total MV duration, reintubation or use of non-invasive MV (NIMV) within 48 h after extubation, in-hospital and intensive care unit (ICU) mortality, in-hospital and ICU length of stay (LOS) (PROSPERO registration No:CRD42021270299)., Results: Twenty RCTs were finally included. Compared to PSV, NAVA was associated with significantly lower risk for in-hospital and ICU death and lower requirements for post-extubation NIMV. Moreover, PAV showed significant advantage over PSV in terms of weaning rates, MV duration and ICU LOS. No significant differences were found between ASV or Smart care/PS and PSV., Conclusions: Moderate certainty evidence suggest that PAV increases weaning success rates, shortens MV duration and ICU LOS compared to PSV. It is also noteworthy that NAVA seems to improve in-hospital and ICU survival., Competing Interests: Declaration of Competing Interest None., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
24. Hydropneumothorax With Persistent Air Leak in a Patient With Mild COVID-19 Disease.
- Author
-
Pantazopoulos IN, Pagonis A, Perlepe G, Kampolis CF, and Gourgoulianis KI
- Abstract
COVID-19 is a pandemic viral disease with a catastrophic global impact. The severity of COVID-19 symptoms ranges from very mild to severe and affects mainly the respiratory system. Spontaneous pneumothorax and pleural effusion are rarely seen in spontaneously breathing COVID-19 patients. We herein report a case of a patient with mild COVID-19 disease presenting to the emergency department with hydropneumothorax. Due to persistent air leak, the patient was managed with video-assisted thoracoscopic surgery (VATS) bullectomy and talc pleurodesis. Clinicians managing these patients should be alert to early diagnose this complication., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2022, Pantazopoulos et al.)
- Published
- 2022
- Full Text
- View/download PDF
25. Bronchocentric granulomatosis in rheumatoid arthritis: case report and literature review.
- Author
-
Pitsilka DA, Kampolis CF, Rontogianni D, Zisis C, Loukeri AA, and Vlachoyiannopoulos PG
- Subjects
- Aged, Bronchi, Female, Granuloma, Humans, Radiography, Arthritis, Rheumatoid complications, Bronchial Diseases complications, Bronchial Diseases diagnostic imaging
- Abstract
Bronchocentric granulomatosis (BcG) is characterized by granulomatous destruction of bronchial or bronchiolar walls and adjacent parenchyma, with debris and exudates filling the airway lumen. Approximately 50% of total cases have been associated with asthma and allergic bronchopulmonary aspergillosis, while it has been rarely reported in the context of rheumatoid arthritis (RA). We describe the case of a 69-year-old female RA patient with BcG presenting as a solitary cavitary pulmonary mass. In addition, we conducted a literature review about the clinical and imaging features of BcG in RA patients. A chronically immunosuppressed 69-year-old female patient with a 16-year history of RA presented with constitutional symptoms (low-grade fever, excessive sweating and malaise) and a sizeable cavitary lung lesion. Open lung biopsy was performed and histopathological findings were consistent with the diagnosis of BcG. Other seven cases of BcG have been previously reported in the context of RA, with clinical and laboratory characteristics described in five of them. Overall, pulmonary nodules or masses were the most frequent imaging finding of BcG, while no clear relationship with disease activity or previous treatment modalities could be established. Surgical resection followed by administration of oral steroids was effective for achieving complete remission of symptoms and radiological stability in most cases.
- Published
- 2020
26. Primary Hemangiopericytoma Arising in Extralobar Pulmonary Sequestration: A Coincidence or Two Rare Disorders?
- Author
-
Kampolis CF, Damaskos C, Loukeri AA, Garmpis N, Garmpi A, Tomos I, Spartalis E, Dimitroulis D, Patsouras A, Douskou M, Papiris SA, and Tomos P
- Subjects
- Aged, Biomarkers, Biopsy, Bronchopulmonary Sequestration surgery, Diagnosis, Differential, Female, Hemangiopericytoma surgery, Humans, Symptom Assessment, Tomography, X-Ray Computed, Treatment Outcome, Bronchopulmonary Sequestration complications, Bronchopulmonary Sequestration diagnosis, Hemangiopericytoma diagnosis, Hemangiopericytoma etiology
- Abstract
Background/aim: Extralobar pulmonary sequestration (EPS) is an unusual congenital defect characterized by the presence of non-functioning lung tissue receiving arterial supply from the systemic arteries. Primary hemangiopericytoma (HPC) is an uncommon potentially malignant tumor of vascular origin that usually involves the soft tissue of the extremities or retroperitoneum, but extremely rarely affects the lung. We present the rare case of a primary pulmonary HPC arising in an EPS., Case Report: A 65-year-old woman, with dyspnea and pleuritic chest pain, was referred for further investigation. Radiological evaluation demonstrated a well-circumscribed mass above the right hemidiaphragm, receiving its arterial supply from the descending thoracic aorta. The patient underwent a right posterolateral thoracotomy and a middle lobectomy. The intraoperative finding was a well-encapsulated solid mass. The histological evaluation described HPC., Results: The patient remains fit and healthy., Conclusion: Pulmonary HPC can arise in EPS. Surgical excision is the treatment of choice., (Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
27. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome.
- Author
-
Kampolis CF, Fragkioudaki S, Mavragani CP, Zormpala A, Samakovli A, and Moutsopoulos HM
- Subjects
- Aged, Chronic Disease, Comorbidity, Cough diagnostic imaging, Cough immunology, Cough physiopathology, Cross-Sectional Studies, Dyspnea diagnostic imaging, Dyspnea immunology, Dyspnea physiopathology, Female, Greece epidemiology, Humans, Lung Diseases, Interstitial diagnostic imaging, Lung Diseases, Interstitial immunology, Lung Diseases, Interstitial physiopathology, Male, Middle Aged, Prevalence, Raynaud Disease epidemiology, Raynaud Disease immunology, Respiratory Function Tests, Risk Factors, Sjogren's Syndrome diagnosis, Sjogren's Syndrome immunology, Tomography, X-Ray Computed, Cough epidemiology, Dyspnea epidemiology, Lung diagnostic imaging, Lung immunology, Lung physiopathology, Lung Diseases, Interstitial epidemiology, Sjogren's Syndrome epidemiology
- Abstract
Objectives: The present cross-sectional study aimed to estimate the prevalence of chronic respiratory symptoms in primary Sjögren's syndrome (pSS) and define the clinical, functional and imaging characteristics of symptomatic pulmonary disease in pSS., Methods: Four hundred and fourteen consecutive pSS patients were interviewed for the presence of chronic respiratory complaints (cough and/or dyspnea). Symptomatic pSS patients without respiratory or other comorbidities underwent further investigation with clinical evaluation and assessment with pulmonary functional testing (PFTs) and chest high resolution CT (hrCT) on inspiratory and expiratory phase. Comparison of clinical and laboratory features between symptomatic and asymptomatic pSS patients was also performed., Results: Prevalence of chronic respiratory symptoms in pSS was estimated at 21.5% (89/414). Symptoms were attributed to underlying comorbidities in approximately one third of cases (30/89). Thirty nine of the remaining 59 patients were finally assessed with PFTs and hrCT. Small airway disease was diagnosed in 20 individuals with an obstructive pattern in PFTs and/or compatible radiological signs. Seven patients were diagnosed with interstitial lung disease, while in the remaining 12 pSS patients, with normal PFTs and hrCT, symptoms were attributed to xerotrachea. Raynaud's phenomenon occurred more frequently in symptomatic than asymptomatic patients (p=0.024)., Conclusions: Approximately one fifth of a large cohort of pSS patients presented chronic respiratory symptoms. Small airway disease was the most commonly recognized pulmonary disorder among symptomatic pSS patients, followed by xerotrachea and interstitial lung disease.
- Published
- 2018
28. Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
- Author
-
Damaskos C, Tomos I, Garmpis N, Karakatsani A, Dimitroulis D, Garmpi A, Spartalis E, Kampolis CF, Tsagkari E, Loukeri AA, Margonis GA, Spartalis M, Andreatos N, Schizas D, Kokkineli S, Antoniou EA, Nonni A, Tsourouflis G, Markatos K, Kontzoglou K, Kostakis A, and Tomos P
- Subjects
- Antineoplastic Agents pharmacology, Carcinoma, Non-Small-Cell Lung enzymology, Histone Deacetylase Inhibitors pharmacology, Humans, Lung Neoplasms enzymology, Antineoplastic Agents therapeutic use, Carcinoma, Non-Small-Cell Lung drug therapy, Histone Deacetylase Inhibitors therapeutic use, Lung Neoplasms drug therapy
- Abstract
Non-small cell lung cancer constitutes the most common type of lung cancer, accounting for 85-90% of lung cancer, and is a leading cause of cancer-related death. Despite the progress during the past years, poor prognosis remains a challenge and requires further research and development of novel antitumor treatment. Recently, the role of histone deacetylases in gene expression has emerged showing their regulation of the acetylation of histone proteins and other non-histone protein targets and their role in chromatin organization, while their inhibitors, the histone deacetylase inhibitors, have been proposed to have a potential therapeutic role in diverse malignancies, including non-small cell lung cancer. This review article focuses on the role of histone deacetylase inhibitors in the treatment of non-small cell lung cancer and the major molecular mechanisms underlying their antitumor activity recognized so far., (Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
29. Benign metastasizing leiomyoma presenting as cavitating lung nodules.
- Author
-
Loukeri AA, Pantazopoulos IN, Tringidou R, Giampoudakis P, Valaskatzi A, Loukeri PA, and Kampolis CF
- Subjects
- Female, Humans, Hysterectomy, Leiomyoma surgery, Lung Neoplasms diagnosis, Lung Neoplasms surgery, Middle Aged, Multiple Pulmonary Nodules diagnosis, Multiple Pulmonary Nodules surgery, Uterine Neoplasms surgery, Leiomyoma pathology, Lung Neoplasms secondary, Multiple Pulmonary Nodules secondary, Uterine Neoplasms pathology
- Abstract
Benign metastasizing leiomyoma (BML) was initially used to describe single or multiple pulmonary nodules composed of proliferating smooth muscle cells (lacking cellular atypia) in premenopausal females 3 months to 20 y after hysterectomy for uterine leiomyoma. The lung is the most commonly involved site, thus including many malignant and benign entities in the differential diagnosis. The present case refers to a 47-y-old premenopausal woman with a history of subtotal hysterectomy for a uterine leiomyoma presenting with bilateral cavitating pulmonary nodules. A number of nodules were resected by video-assisted thoracoscopic surgery. The histological findings in correlation with the immunohistochemical results were consistent with the diagnosis of BML. A bilateral salpingo-oophorectomy was performed, combined with complete removal of the remaining cervix. One year later, the subject remains asymptomatic, and the pulmonary nodules are stable with regard to number, size, location, and morphology., (Copyright © 2014 by Daedalus Enterprises.)
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.